Guardant Health, Inc. Common Stock (GH) — Analysis Summary
Guardant Health, Inc. Common Stock (GH) has a market cap of $17.20B with year-over-year revenue growth of +32.9%. Net margin stands at -42.4%. The stock trades at a P/E ratio of -39.7.
Key Takeaways
- Revenue changed +32.9% year-over-year
- Net margin of -42.4%
- P/E ratio of -39.7
Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, GH posted revenue growth of +32.9% and trades at a P/E of -39.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.